Ceftazidime for Injection Page 1 of 8
Ceftazidime for Injection
Effective Date: 24-Feb-2001
Eli Lilly and Company
Material Safety Data Sheet
Section 1 - Chemical Product and Company
Manufacturer's Emergency Phone:
Manufacturer:
1-317-276-2000
Eli Lilly and Company
CHEMTREC:
Lilly Corporate Center
1-800-424-9300 (North America)
Indianapolis, IN 46285
1-703-527-3887 (International)
Common Name: Ceftazidime for Injection
Chemical Name: Pyridinium, 1-[[(6R,7R)-7-[[(2Z)-(2-amino-4-thiazolyl)[(1-carboxy-1-methylethoxy)
imino]acetyl]amino]-2-carboxy-
8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl]methyl]-, inner salt, pentahydrate
Synonym(s): Ceftazidime; Ceftazidime Pentahydrate; Ceftazidime Buffered; Buffered Ceftazidime;
139381 Formulation
Trademarks(s): Ftazidime; Kefamin; Kefazim; Kefzim; Zidime; Zetadime; Tazidime; Kefadim; Seftaz
Lilly Item Code(s): CA1527; CA1528; CA1529; FS7245; FS7246; ID4026; ND0878; ND0879;
ND0880; ND0885; ND0886; ND0887; ND0888; ND0928; ND0931; ND0933; QA290X; QA419W;
QA442E; QA442V; QI0235; SI0138; SI0143; UC9506; UC9507; UC9508; UG9000; UG9001;
UG9002; UG9003; UG9004; UG9005; UG9006; VF0188; VF0208; VF0209; VF0210; VF0274;
VF0275; VF0276; VF0327; VF0328; VF0335; VL7230; VL7231; VL7234; VL7235; VL7238;
VL7239; VL7241; VL7242; VL7290; VL7291; VL7292; VL7310; VL7311; VL7314; VL7318;
VL7420; VL7421; VL7422; VL7423; VL7427; VL7460; VL7461; VL7462; VP7460; VP7461; VP7462
See attached glossary for abbreviations.
Section 2 - Composition / Information on Ingredients
Ingredient CAS Concentration %
Ceftazidime Pentahydrate 78439-06-2 88 - 90
Sodium Carbonate Monohydrate 5968-11-6 10 - 12
Contains no hazardous components (one percent or greater) or carcinogens (one-tenth percent or
greater) not listed above.
Exposure Guidelines:
Ceftazidime pentahydrate - LEG <100 micrograms/m3 TWA for 12 hours.
Sodium carbonate anhydrous - Exposure Guideline 500 micrograms/m3 TWA for 12 hours. (Lilly-
established guideline)
file://Z:\Legacy\EXTRACT 30NOV2006\MSDS_html\4268907.html 12/7/2006
Ceftazidime for Injection Page 2 of 8
Section 3 - Hazards Identification
Appearance: White to cream-colored crystalline powder
Physical State: Solid
Odor: Odorless
Emergency Overview
Special
A = Allergen
Emergency Overview Effective Date: 21-Nov-1998
Lilly Laboratory Labeling Codes:
Health 2 Fire 1 Reactivity 1 Special A
Primary Physical and Health Hazards: Irritant (eyes). Severe Allergen.
Caution Statement: Ceftazidime for Injection may be irritating to the eyes and causes severe allergic
reactions.
Routes of Entry: Inhalation and skin contact.
Effects of Overexposure: None reported; however, based on prior experience with cephalosporin
antibiotics, allergic reactions might be expected, including rash, nasal congestion, cough, dry throat, eye
irritation, or anaphylactic shock. Dilute formulations of sodium carbonate may be irritating to the
eyes.
Medical Conditions Aggravated by Exposure: Hypersensitivity to penicillin or cephalosporin.
Carcinogenicity: All ingredients - No carcinogenicity data found. Not listed by IARC, NTP, ACGIH,
or OSHA.
Section 4 - First Aid Measures
Eyes: Hold eyelids open and flush with a steady, gentle stream of water for 15 minutes. See an
ophthalmologist (eye doctor) or other physician immediately.
Skin: Remove contaminated clothing and clean before reuse. Wash all exposed areas of skin with
plenty of soap and water. Get medical attention if irritation develops.
Inhalation: Move individual to fresh air. Get medical attention if breathing difficulty occurs. If not
breathing, provide artificial respiration assistance (mouth-to-mouth) and call a physician immediately.
file://Z:\Legacy\EXTRACT 30NOV2006\MSDS_html\4268907.html 12/7/2006
Ceftazidime for Injection Page 3 of 8
Ingestion: Do not induce vomiting. Call a physician or poison control center. If available, administer
activated charcoal (6-8 heaping teaspoons) with two to three glasses of water. Do not give anything by
mouth to an unconscious person. Immediately transport to a medical care facility and see a physician.
Section 5 - Fire Fighting Measures
Flash Point: No applicable information found
UEL: No applicable information found
LEL: No applicable information found
Extinguishing Media: Use water, carbon dioxide, dry chemical, foam, or Halon.
Unusual Fire and Explosion Hazards: As a finely divided material, may form dust mixtures in air
which could explode if subjected to an ignition source.
Hazardous Combustion Products: May emit toxic fumes when exposed to heat or fire.
Section 6 - Accidental Release Measures
Spills: Wear protective equipment, including eye protection, to avoid exposure (see Section 8 for
specific handling precautions). Vacuum material with appropriate dust collection filter in place. Be
aware of potential for dust explosion when using electrical equipment. If vacuum is not available,
lightly mist material and remove by sweeping or wet wiping.
Section 7 - Handling and Storage
Storage Conditions: Refrigerator: 2 to 8 C (36 to 46 F).
Section 8 - Exposure Controls / Personal Protection
See Section 2 for Exposure Guideline information.
Under normal use and handling conditions, no protective equipment is required. The following is
recommended for a production setting:
Respiratory Protection: Use an approved respirator.
Eye Protection: Chemical goggles and/or face shield.
Ventilation: Laboratory fume hood or local exhaust ventilation.
Other Protective Equipment: Chemical-resistant gloves and body covering to minimize skin
contact. If handled in a ventilated enclosure, as in a laboratory setting, respirator and goggles or face
shield may not be required. Safety glasses are always required.
file://Z:\Legacy\EXTRACT 30NOV2006\MSDS_html\4268907.html 12/7/2006
Ceftazidime for Injection Page 4 of 8
Additional Exposure Precautions: In production settings, airline-supplied, hood-type respirators are
preferred. Shower and change clothing if skin contact occurs.
Section 9 - Physical and Chemical Properties
Appearance: White to cream-colored crystalline powder
Odor: Odorless
Boiling Point: No applicable information found
Melting Point: No applicable information found
Specific Gravity: No applicable information found
pH: 5.0-7.5 (10% aqueous)
Evaporation Rate: No applicable information found
Water Solubility: Soluble
Vapor Density: No applicable information found
Vapor Pressure: No applicable information found
Section 10 - Stability and Reactivity
Stability: Stable at normal temperatures and pressures.
Incompatibility: May react with strong oxidizing agents (e.g., peroxides, permanganates, nitric acid,
etc.) and strong acids.
Hazardous Decomposition: May emit toxic fumes when heated to decomposition.
Hazardous Polymerization: Will not occur.
Section 11 - Toxicological Information
Acute Exposure
Data for the ingredients, ceftazidime pentahydrate and sodium carbonate, are presented where
indicated.
Oral: Ceftazidime pentahydrate - Rat, 500 mg/kg, no deaths or toxicity.
Skin: Ceftazidime pentahydrate - Rabbit, 200 mg/kg, no deaths or toxicity.
Inhalation: Ceftazidime pentahydrate - Rat, 690 mg/m3 for 4 hours, no deaths.
Sodium carbonate anhydrous - Rat, median lethal concentration 2300 mg/m3 for 2 hours (approximately
4600 mg/m3 for 1 hour).
Intravenous: Ceftazidime pentahydrate - Rat, 2581 mg/kg, no deaths.
Monkey, 1500 mg/kg, no deaths, soft stools, diarrhea.
Skin Contact: Ceftazidime pentahydrate - Rabbit, nonirritant
file://Z:\Legacy\EXTRACT 30NOV2006\MSDS_html\4268907.html 12/7/2006
Ceftazidime for Injection Page 5 of 8
Eye Contact: Ceftazidime pentahydrate - Rabbit, slight irritant
Sodium carbonate anhydrous - Rabbit, moderate to severe irritant
Rabbit, mild irritant (rinsed)
Chronic Exposure
Data for the active ingredient, ceftazidime pentahydrate, are reported.
Target Organ Effects: Ceftazidime pentahydrate - Blood effects (decreased red blood cell count,
increased white blood cell count, decreased activated partial prothrombin time values), liver effects
(increased liver weight), kidney effects (increased kidney weight, kidney tissue changes).
Other Effects: Ceftazidime pentahydrate - Salivation, vomiting, and soft or mucoid stools.
Reproduction: Ceftazidime pentahydrate - No effects identified in animal studies.
Sensitization: No applicable information found.
Mutagenicity: Ceftazidime pentahydrate - Not mutagenic in bacterial or mammalian cells.
Section 12 - Ecological Information
No environmental data for the mixture or formulation. The environmental information for ingredient(s)
or related material(s) are presented.
Ecotoxicity Data:
Sodium carbonate anhydrous
Bluegill 96-hour median lethal concentration: 300 to 320 mg/L
Fathead minnow 96-hour median lethal concentration: <850 mg/L
Daphnia magna 96-hour median lethal concentration: 265 to 565 mg/L
Environmental Fate: No applicable information found.
Environmental Summary:
Sodium carbonate anhydrous - Material is practically non-toxic to aquatic organisms. Material is
soluble in water and is expected to leach from soil into groundwater
Section 13 - Disposal Considerations
Waste Disposal: Dispose of any cleanup materials and waste residue according to all applicable laws
and regulations.
Section 14 - Transport Information
Regulatory Organizations:
DOT: Not Regulated
file://Z:\Legacy\EXTRACT 30NOV2006\MSDS_html\4268907.html 12/7/2006
Ceftazidime for Injection Page 6 of 8
ICAO/IATA: Not Regulated
IMO: Not Regulated
Section 15 - Regulatory Information
Below is selected regulatory information chosen primarily for possible Eli Lilly and Company
usage. This section is not a complete analysis or reference to all applicable regulatory
information. Please consider all applicable laws and regulations for your country/state.
U.S. Regulations
Ceftazidime pentahydrate
TSCA - No
CERCLA - Not on this list
SARA 302 - Not on this list
SARA 313 - Not on this list
OSHA Substance Specific - No
Remaining Ingredients
TSCA - Yes
CERCLA - Not on this list
SARA 302 - Not on this list
SARA 313 - Not on this list
OSHA Substance Specific - No
EU Regulations
EC Classification
Contains ceftazidime pentahydrate (C = 88 to 90%)
Xn (Harmful)
Xi (Irritant)
Risk Phrases
R 36 - Irritating to eyes.
R 42/43 - May cause sensitization by inhalation and skin contact.
Safety Phrases
S 25 - Avoid contact with eyes.
S 26 - In case of contact with eyes, rinse immediately with plenty of water and seek medical advice.
S 36/37/39 - Wear suitable protective clothing, gloves and eye/face protection.
Section 16 - Other Information
MSDS Sections Revised: Section 1.
As of the date of issuance, we are providing available information relevant to the handling of this
material in the workplace. All information contained herein is offered with the good faith belief that it
file://Z:\Legacy\EXTRACT 30NOV2006\MSDS_html\4268907.html 12/7/2006
Ceftazidime for Injection Page 7 of 8
is accurate. THIS MATERIAL SAFETY DATA SHEET SHALL NOT BE DEEMED TO CREATE
ANY WARRANTY OF ANY KIND (INCLUDING WARRANTY OF MERCHANTABILITY OR
FITNESS FOR A PARTICULAR PURPOSE). In the event of an adverse incident associated with this
material, this safety data sheet is not intended to be a substitute for consultation with appropriately
trained personnel. Nor is this safety data sheet intended to be a substitute for product literature which
may accompany the finished product.
For additional information contact:
Eli Lilly and Company
Hazard Communication
317-277-6029
For additional copies contact:
Eli Lilly and Company
1-800-LILLY-Rx (1-800-545-5979)
GLOSSARY:
ACGIH = American Conference of Governmental Industrial Hygienists
AIHA = American Industrial Hygiene Association
BEI = Biological Exposure Index
CAS Number = Chemical Abstract Service Registry Number
CERCLA = Comprehensive Environmental Response Compensation and Liability Act (of 1980)
CHAN = Chemical Hazard Alert Notice
CHEMTREC = Chemical Transportation Emergency Center
DOT = Department of Transportation
EC = European Community
EINECS = European Inventory of Existing Chemical Substances
ELINCS = European List of New Chemical Substances
EPA = Environmental Protection Agency
HEPA = High Efficiency Particulate Air (Filter)
IARC = International Agency for Research on Cancer
ICAO/IATA = International Civil Aviation Organization/International Air Transport Association
IEG = Lilly Interim Exposure Guideline
IMO = International Maritime Organization
Kow = Octanol/Water Partition Coefficient
LEG = Lilly Exposure Guideline
LEL = Lower Explosive Limit
MSDS = Material Safety Data Sheet
MSHA = Mine Safety and Health Administration
NA = Not Applicable, except in Section 14 where NA = North America
NADA = New Animal Drug Application
NAIF = No Applicable Information Found
NCI = National Cancer Institute
NIOSH = National Institute for Occupational Safety and Health
NOS = Not Otherwise Specified
NTP = National Toxicology Program
OSHA = Occupational Safety and Health Administration
PEL = Permissible Exposure Limit (OSHA)
RCRA = Resource Conservation and Recovery Act
RQ = Reportable Quantity
file://Z:\Legacy\EXTRACT 30NOV2006\MSDS_html\4268907.html 12/7/2006
Ceftazidime for Injection Page 8 of 8
RTECS = Registry of Toxic Effects of Chemical Substances
SARA = Superfund Amendments and Reauthorization Act
STEG = Lilly Short Term Exposure Guideline
STEL = Short Term Exposure Limit
TLV = Threshold Limit Value (ACGIH)
TPQ = Threshold Planning Quantity
TSCA = Toxic Substances Control Act
TWA = Time Weighted Average/8 Hours Unless Otherwise Noted
UEL = Upper Explosive Limit
UN = United Nations
WEEL = Workplace Environmental Exposure Level (AIHA)
file://Z:\Legacy\EXTRACT 30NOV2006\MSDS_html\4268907.html 12/7/2006
|